TrademarkDir
Serial #79075435
LIVE

Serial Number

79075435

Owner

Santaris Pharma A/S

Filing Date

Aug 13, 2009

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #79075435 Trademark

Serial Number: 79075435 • Registration: 3960665

Serial #79075435 is a trademark filed by Santaris Pharma A/S on August 13, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Santaris Pharma A/S (4 trademarks)

Kogle Alle 6
2970 Hørsholm , DK

Entity Type: 03

Trademark Details

Filing Date

August 13, 2009

Registration Date

May 17, 2011

Published for Opposition

March 1, 2011

Cancellation Date

August 13, 2019

Goods & Services

pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseases

chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and development

scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and products

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 6, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 6, 2020 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 7, 2018 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 10, 2018 INTS
INVALIDATION PROCESSED
Sep 10, 2018 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 22, 2018 INTR
CANCELLED SECTION 71
Dec 22, 2017 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2014 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 24, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 6, 2011 FICS
FINAL DISPOSITION PROCESSED
Oct 5, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 17, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
May 17, 2011 R.PR
PUBLISHED FOR OPPOSITION
Mar 1, 2011 PUBO
NOTICE OF PUBLICATION
Feb 9, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 25, 2011 PREV
ASSIGNED TO LIE
Jan 21, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2010 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 21, 2010 ERFR
FINAL REFUSAL MAILED
Jun 29, 2010 CNFR
FINAL REFUSAL WRITTEN
Jun 29, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2010 TROA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 23, 2010 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 18, 2010 CRCV
REFUSAL PROCESSED BY IB
Jan 22, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2009 RFCS
REFUSAL PROCESSED BY MPU
Dec 11, 2009 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 11, 2009 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 10, 2009 RFCR
NON-FINAL ACTION WRITTEN
Dec 9, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 7, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2009 REPR

Related Trademarks

More from this Owner

LNA-ANTIMIR

LNA-ANTIMIR

SANTARIS PHARMA A/S

SANTARIS PHARMA A/S

SANTARIS PHARMA A/S

SANTARIS PHARMA A/S

SANTARIS PHARMA A/S

SANTARIS PHARMA A/S

CUREON

CUREON

CUREON

CUREON